KSC-12-192

KSC-12-192

KSC-12-192 is a chemical compound with potential applications in the field of pharmacology. It is a member of the quinazoline family of compounds, which are known for their diverse range of biological activities.

Chemical Structure

KSC-12-192 is a quinazoline derivative. The quinazoline nucleus is a bicyclic system, consisting of two fused six-membered rings, one of which is aromatic (benzene) and the other is not (pyrimidine). The quinazoline nucleus is a key structural motif in a variety of natural products and pharmaceutical agents.

Pharmacological Applications

The quinazoline derivatives, including KSC-12-192, have been studied for their potential pharmacological applications. They have shown promise in a variety of areas, including oncology, neurology, and cardiology. In particular, some quinazoline derivatives have demonstrated potent anti-cancer activity, making them a focus of research in oncology.

Research and Development

Research into the potential applications of KSC-12-192 is ongoing. Early studies have indicated that it may have potential as a therapeutic agent in the treatment of certain types of cancer. However, further research is needed to fully understand its mechanisms of action and potential side effects.

See Also

• Quinazoline
• Pharmacology
• Oncology
• Neurology
• Cardiology

   This article is a Chemical compound-related stub. You can help WikiMD by expanding it!

This article is a stub related to pharmacology. You can help WikiMD by expanding it!

   This article is a oncology stub. You can help WikiMD by expanding it!

   This article is a  stub. You can help WikiMD by expanding it!

   This article is a cardiovascular system stub. You can help WikiMD by expanding it!